Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-20-003710
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-07 18:00:40
Reporting Period:
2020-02-05
Accepted Time:
2020-02-07 18:00:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623613 Mylan N.v. MYL Pharmaceutical Preparations (2834) 981189497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657568 Paul Campbell Building 4, Trident Place, Mosquito Way
Hatfield, Hertfordshire X0 AL10 9UL
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares (Pursuant To Existing Trading Plan) Acquisiton 2020-02-05 11,611 $21.13 37,024 No 4 X Direct
Ordinary Shares (Pursuant To Existing Trading Plan) Disposition 2020-02-05 11,611 $23.00 25,413 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option - Right to Buy Disposition 2020-02-05 11,611 $0.00 11,611 $21.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-03-03 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 318 Indirect By 401(k) Plan
Footnotes
  1. The exercise of stock options and sale of ordinary shares were executed pursuant to a 10b5-1 trading plan executed on December 10, 2019.
  2. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 3, 2010.
  3. These options vested in three equal annual installments beginning on March 3, 2011.